LANCET HIV《柳叶刀·艾滋病》（月刊）。The Lancet HIV launched in autumn 2014, joining the growing collection of Lancet specialty journals. As an exclusively online journal, this monthly title is dedicated to publishing original research, evidence-based reviews and insightful features that advocates for change in or illuminates HIV clinical practice. A Fast Track review process is available on request and at the Editor’s discretion, whereby the most topical research papers can be published online within 8 weeks of submission.

Cytokine《细胞因子》（月刊）. Cytokine will publish studies that report on the molecular biology, signal transduction, genetics, biochemistry, immunology, genome-wide association, pathobiology, diagnostic, clinical, and therapeutic applications of all known and emerging cytokines, cytotoxins, interferons, chemokines, adipokines, matrikines, hematopoietic factors, and growth factors. Studies reporting all signaling molecules from the pathogens and host-endogenous sources, metabolic products/adducts that mediate inflammation and immunity, either influence and/or operate under this broad class of "biological response modifiers" as they relate to host defenses and immune responses will be considered for publication.

BioDrugs《生物药物》（双月刊）. BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease.

Vaccine《疫苗》（一年26期）. Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions. We also invite authors to submit relevant basic science and clinical reviews, methodological articles, opinion and commentary pieces, visual pieces, and letters. Authors are required to consult the Guide for Authors as the submission guidelines are dynamic and therefore subject to change.

APMIS《斯堪的纳维亚病理学、微生物学和免疫学学报》（月刊）. APMIS, formerly Acta Pathologica, Microbiologica et Immunologica Scandinavica, has been published since 1924 by the Scandinavian Societies for Medical Microbiology and Pathology as a non-profit-making scientific journal. The aim of APMIS is to publish original research in the fields of pathology, microbiology and immunology, and from related developing areas of modern biomedicine. APMIS has subscribers worldwide.

COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES《比较免疫学，微生物学与传染病》（双月刊）。Comparative Immunology, Microbiology & Infectious Diseases aims to respond to the concept of "One Medicine" and to provide a venue for scientific exchange. Based on the concept of "Comparative Medicine" interdisciplinary cooperation between specialists in human and animal medicine is of mutual interest and benefit. Therefore, there is need to combine the respective interest of physicians, veterinarians and other health professionals for comparative studies relevant to either human or animal medicine .

Autoimmunity《自身免疫》（一年1卷）. Autoimmunity is an international, peer reviewed journal that publishes articles on cell and molecular immunology, immunogenetics, molecular biology and autoimmunity. Current understanding of immunity and autoimmunity is being furthered by the progress in new molecular sciences that has recently been little short of spectacular. In addition to the basic elements and mechanisms of the immune system, Autoimmunity is interested in the cellular and molecular processes associated with systemic lupus erythematosus, rheumatoid arthritis, Sjogren syndrome, type I diabetes, multiple sclerosis and other systemic and organ-specific autoimmune disorders.